Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 26 min ago
PreprintAll rights reservedbioRxiv

A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer

1 more authors
  1. 1Texas A & M University

Related

  1. HIF-1α-driven lactate from mesenchymal stem/stromal cells reprograms monocyte metabolism and suppresses autoimmune uveoretinitis
    Hyun Ju Lee, Jung Hwa Ko, Jin Suk Ryu +1
    Cell ReportsPeer-reviewedCC BY 4.0General medicineCrossref
  2. A Tumor-Pituitary-Stromal Axis Promotes Colorectal Cancer Progression
    W. Li, S. Wang, H. Wu +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. Leptin receptor deficiency suppresses gastric tumorigenesis by limiting stromal activation and tumor microenvironment development.
    K. Inagaki-Ohara, D. Motooka, I. Yamanaka +11
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  4. Same organ, divergent immunity: T-cell exhaustion versus stromal exclusion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    YanXi Chen, Tao Peng, Hao Nie +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  5. FDX1 suppresses acute myeloid leukemia progression and reverses cuproptosis resistance via the ROS/p53/ME1 axis
    Lihua Yao, Fangmin Zhong, Qin Bai +9
    iSciencePeer-reviewedCC BY 4.0Molecular biology & gene regulationOncologyCell PressCrossref
BibTeX
@misc{carter2026stromal,
  title = {{A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer}},
  author = {K. Carter and O. Ogunlusi and M. Sarkar and S. Akanbi and C. Nguyen and M. Nekkanti and A. Agarwal and D. Fails and G. Nawaratna and C. Klemashevich and J. Cai and D. J. Boland and T. Roy Sarkar},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.07.749862},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.07.749862v1},
}
RIS
TY  - UNPB
TI  - A stromal metabolic program suppresses NK-cell immunity to drive tumor progression in HER2-low breast cancer
AU  - K. Carter
AU  - O. Ogunlusi
AU  - M. Sarkar
AU  - S. Akanbi
AU  - C. Nguyen
AU  - M. Nekkanti
AU  - A. Agarwal
AU  - D. Fails
AU  - G. Nawaratna
AU  - C. Klemashevich
AU  - J. Cai
AU  - D. J. Boland
AU  - T. Roy Sarkar
PY  - 2026
DA  - 2026/09/07
PB  - bioRxiv
DO  - 10.64898/2026.09.07.749862
UR  - https://www.biorxiv.org/content/10.64898/2026.09.07.749862v1
ER  -